https://seekingalpha.com/news/4140530-bristol-myers-novartis-slam-medicare-prices-key-drugs?source=feed_sector_healthcare
Aug 15, 2024 - Bristol Myers Squibb (BMY) and Novartis (NVS) criticize the U.S. government as Medicare announces revised prices for their blockbuster therapies. Read more here.
0
sa:-8862899413345139039
0
https://www.zacks.com/stock/news/2322656/compared-to-estimates-cerberus-telecom-acquisition-kore-q2-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2322656
Aug 15, 2024 - The headline numbers for Cerberus Telecom Acquisition (KORE) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:4215690434847636031
0
https://www.zacks.com/stock/news/2322530/deere-de-reports-q3-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2322530
Aug 15, 2024 - The headline numbers for Deere (DE) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-473280041548536965
0
https://www.zacks.com/stock/news/2322533/compared-to-estimates-nice-nice-q2-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2322533
Aug 15, 2024 - The headline numbers for Nice (NICE) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-963624552974762815
0
https://www.zacks.com/stock/news/2322531/compared-to-estimates-tapestry-tpr-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2322531
Aug 15, 2024 - The headline numbers for Tapestry (TPR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-2646275071105872082
0
https://www.zacks.com/stock/news/2322532/walmart-wmt-reports-q2-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2322532
Aug 15, 2024 - The headline numbers for Walmart (WMT) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:691480487285287789
0
https://www.zacks.com/stock/news/2322490/unlocking-q2-potential-of-lowe-s-low-exploring-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2322490
Aug 15, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Lowe's (LOW), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2024.
zc:-4188048634330678253
0
https://www.zacks.com/stock/news/2322493/seeking-clues-to-medtronic-mdt-q1-earnings-a-peek-into-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2322493
Aug 15, 2024 - Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended July 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
zc:2181902839445849955
0
https://www.zacks.com/stock/news/2322492/countdown-to-alcon-alc-q2-earnings-wall-street-forecasts-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2322492
Aug 15, 2024 - Get a deeper insight into the potential performance of Alcon (ALC) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
zc:-2156723043463487301
0
https://www.zacks.com/stock/news/2322491/what-analyst-projections-for-key-metrics-reveal-about-coty-coty-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2322491
Aug 15, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Coty (COTY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
zc:4963684185790544495
0